Search

The article presents 2012 and 2013 news on regulatory action related to drugs. The U.S. Food and Drug Administration has announced that it is forming an internal task force to support development of new antibacterial drugs. Great Britain's National Institute for Biological Standards and Control will become a part of the Medicines and Healthcare products Regulatory Agency on April 1, 2013. The government of Pakistan enacted the Drug Regulatory Authority of Pakistan bill on November 12, 2012.

The article reports that the U.S. Food and Drug Administration (FDA) has approved trametinib (Mekinist) and dabrafenib (Tafinlar) for the treatment of patients with unresectable or metastatic melanoma.

The article reports on a decision which the manufacturer of the cancer treatment drug gemtuzumab ozogamicin made to withdraw the drug from the U.S. market after the U.S. Food and Drug Administration raised questions about the drug's safety and efficacy.